Year |
Title |
Other authors |
Journal and Publisher /
Conference |
Vol. |
Pages |
2019 |
Adrenal Aging and Its Implications on Stress Responsiveness in Humans. |
Yiallouris A, Tsioutis C, Agapidaki E, Zafeiri M, Agouridis AP, Ntourakis D, Johnson EO |
Front Endocrinol |
10 |
|
2016 |
Effect of rosuvastatin or its combination with omega-3 fatty acids on circulating CD34(+) progenitor cells and on endothelial colony formation in patients with mixed dyslipidaemia. |
Chantzichristos VG, Agouridis AP, Moutzouri E, Stellos K, Elisaf MS, Tselepis AD |
Atherosclerosis |
251 |
240-7 |
2015 |
All for Statins and Statins for All; An Update |
Agouridis AP, Elisaf MS, Nair DR, Mikhailidis DP |
Curr Pharm Des |
22 |
18-27 |
2015 |
Statins and their increased risk of inducing diabetes |
Agouridis AP, Kostapanos MS, Elisaf MS |
Expert Opin Drug Saf |
14 |
1835-44 |
2015 |
Variable effects of statins on glucose homeostasis parameters and their diabetogenic role |
Kostapanos MS, Agouridis AP, Elisaf MS |
Diabetologia |
58(8) |
1960-1 |
2015 |
Strategies to overcome statin intolerance |
Agouridis AP, Nair DR, Mikhailidis DP |
Expert Opin Drug Metab Toxicol |
11 |
851-5 |
2015 |
New-onset extremely low levels of high-density lipoprotein cholesterol |
Agouridis AP, Liberopoulos EN, Kostapanos MS, Elisaf MS |
J Clin Lipidol |
6 |
593-5 |
2012 |
Effect of rosuvastatin monotherapy or in combination with fenofibrate or omega-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome |
Agouridis AP, Kostapanos MS, Tsimihodimos V, Kostara C, Mikhailidis DP, Bairaktari ET, Tselepis AD, Elisaf MS |
Int J Clin Pract |
66(9) |
843-53 |
2011 |
The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia |
Agouridis AP, Tsimihodimos V, Filippatos TD, Dimitriou AA, Tellis CC, Elisaf MS, Mikhailidis DP, Tselepis AD |
Expert Opin Pharmacother |
12(17) |
2605-11 |
2011 |
High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia |
Agouridis AP, Tsimihodimos V, Filippatos TD, Tselepis AD, Elisaf MS |
Lipids |
46(6) |
521-8 |